Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab

Cancer Science
Shiro KimbaraYuichiro Ohe

Abstract

Thyroid dysfunction (TD) induced by immune checkpoint inhibitors is not sufficiently understood. The purpose of this retrospective observational study was to identify risk factors and the clinical course of TD induced by nivolumab. Patients with advanced solid tumors who were treated with nivolumab from March 2009 through to March 2016 at the National Cancer Center Hospital (Tokyo, Japan) were included. Thyroid function and antithyroid Abs from serum samples among all patients were evaluated at baseline and during nivolumab treatment. Overt hypothyroidism was defined as low serum-free T4 together with elevated thyroid-stimulating hormone (TSH) >10 μIU/mL. Thyrotoxicosis was defined as low TSH with elevated free T4 and/or free T3. We defined thyroid autoimmunity as the presence of antithyroid Abs at baseline, including antithyroid peroxidase Abs and antithyroglobulin Abs (TgAb). Twenty-three (14%) of a total of 168 patients developed TD, including 17 cases of hypothyroidism and 20 of thyrotoxicosis. Thyrotoxicosis followed by hypothyroidism occurred in 14 cases. Fourteen of 35 patients (40%) with thyroid autoimmunity developed TD vs 9 of 133 (7%) without (odds ratio 9.19; 95% confidence interval [CI], 3.53-23.9). In multivariate...Continue Reading

References

Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jan 20, 2012·The Journal of Clinical Endocrinology and Metabolism·Margret EhlersMatthias Schott
Mar 9, 2013·The Journal of Clinical Endocrinology and Metabolism·Salvatore Maria CorselloFrancesco Torino
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Mar 10, 2015·The Journal of Clinical Endocrinology and Metabolism·Steven OrlovPaul G Walfish
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 26, 2015·The New England Journal of Medicine·Robert J MotzerUNKNOWN CheckMate 025 Investigators
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Oct 9, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Morganna Freeman-KellerJeffrey Weber
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Oct 22, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S KandaT Tamura
Dec 9, 2016·Investigational New Drugs·Noboru YamamotoTomohide Tamura
Apr 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert ChenUNKNOWN KEYNOTE-087
Oct 14, 2017·Endocrine-related Cancer·Priscilla CukierAna O Hoff
Feb 15, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerUNKNOWN National Comprehensive Cancer Network
Mar 31, 2018·Journal of the Endocrine Society·Tomoko KobayashiHiroshi Arima

❮ Previous
Next ❯

Citations

Jan 31, 2020·Expert Review of Anticancer Therapy·Caroline A Nebhan, Douglas B Johnson
Mar 11, 2020·Thyroid : Official Journal of the American Thyroid Association·Edwin A BasakMarco Medici
Apr 30, 2020·Immunotherapy·Maria V DeligiorgiDimitrios T Trafalis
Sep 25, 2019·International Journal of Clinical Oncology·Hidetoshi Hayashi, Kazuhiko Nakagawa
Jun 13, 2019·Interdisciplinary Sciences, Computational Life Sciences·Xinyong ZhangShucai Zhang
Jul 3, 2020·Journal of Clinical Medicine·Naoko OkuraKoichi Takayama
Aug 19, 2020·Immunotherapy·Mary AlbrethsenJohn Nemunaitis
Aug 23, 2019·The New England Journal of Medicine·Henry B Burch
Aug 28, 2020·BMC Endocrine Disorders·Hiroshi YamadaHitoshi Sugihara
Sep 15, 2020·Frontiers in Molecular Neuroscience·Martin KrennFritz Zimprich
Jan 7, 2020·Therapeutic Advances in Endocrinology and Metabolism·Edson NogueiraDaniel L Morganstein
May 27, 2020·American Society of Clinical Oncology Educational Book·William B McKeanSiwen Hu-Lieskovan
Apr 8, 2020·BMJ : British Medical Journal·Karmela K Chan, Anne R Bass
Aug 28, 2020·Journal of Community Hospital Internal Medicine Perspectives·Waqas HaqueMihail Zilbermint
Apr 9, 2020·Thyroid : Official Journal of the American Thyroid Association·Christopher A MuirVenessa H M Tsang
Dec 28, 2019·Bulletin du cancer·Christine Cugnet AnceauEmmanuel Disse
Oct 17, 2020·Cancer Management and Research·Quentin DurrechouAmaury Daste
Dec 29, 2020·Journal of Endocrinological Investigation·L BrilliM G Castagna
Mar 1, 2021·Current Opinion in Immunology·Ana Luisa PerdigotoKevan C Herold
Mar 2, 2021·Frontiers in Oncology·Josefien W HommesDörte Hamann
Nov 19, 2020·JHEP Reports : Innovation in Hepatology·Eleonora De MartinDidier Samuel
May 1, 2021·Cancers·Mathilde PeiffertJuliette Abeillon-du Payrat
Apr 21, 2021·The Journal of Clinical Endocrinology and Metabolism·Christopher A MuirAlexander M Menzies
Aug 25, 2021·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Yoshikazu TakahashiMasashi Fujii
Sep 19, 2021·International Journal of Cancer. Journal International Du Cancer·Lei XuXiaoping Chen
Nov 19, 2021·The Journal of Clinical Endocrinology and Metabolism·Shintaro IwamaHiroshi Arima

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy

Software Mentioned

spss

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.